Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Medtronic Insulin Pumps Recalled Due to Cybersecurity Concerns

The FDA is warning patients and healthcare providers that Medtronic MiniMed insulin pumps have potential cybersecurity issues.

Recalled MiniMed / Image: iStock
Recalled MiniMed / Image: iStock

A recent article from The Washington Post discussed the recall of two Medtronic insulin pumps due to cybersecurity concerns. According to the FDA, The MiniMed 508 and the MiniMed Paradigm are vulnerable to hackers who might connect to the device and change the amount of insulin delivered. If a patient receives too much insulin, they could risk hypoglycemia, and if they receive too little, they run the risk of hyperglycemia and diabetic ketoacidosis.

Although no incidents have been reported, the risk of patient harm if the concerns were left unaddressed is significant. Because the devices cannot be updated, Medtronic is providing alternative pumps to patients with more robust cybersecurity capabilities.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging